Historical Outline
Idea Conceived,
December 2006
Review Published,
March 2007
Pure One™ Conceived,
May 2007
Company Founded,
October 2007
www.Source-Omega.com (World) Website Launched,
March 2008
Pure One™ Product Pilot Launched,
May 2009
Pure One™ Wholesale Begins with Great Earth,
September 2008
Sponsorship Given to Filippo Porco,
January 2009
Patent Pending Application,
March 2009
Entered Top Online Vegan Stores,
April 2009
First Full Product Manufacturing Run,
July 2009
Product Endorsed by Iron-Doc™ Alex McDonald, MD,
August 2009
New Pure One™ Logo Created,
August 2009
New Source-Omega™ Logo Created,
September 2009
Swedish Export Partnership with Veganlife Formed,
October 2009
Pure One™ in first clinic TrueNorth Health,
November 2009
www.Pure-One.se (Sweden) Launched,
November 2009
www.Pure-One.eu (Europe) Launched,
December 2009
Liquid Pure One™ Oil – 3 ounce Flask Launched,
December 2009
www.PureOne-DHA.com (World) Launched,
January 2010
Executive Summary
1) PLAN: Pure One™ has an exclusive US formulation and use strategy, Patent Pending. Pure One™ - Next Generation Plant Based Omega-3 and branding strategy will aim to capture larger and broader market share online and offline and through wholesales in the USA and Europe. Pure One™ shall replace Source-Omega™ as the main brand in the 2010 architecture.
Pure One™ is re-branding its logo to help fuel successful market positions. The new branding and designs appeal to broad audiences in omega-3 supplement markets. The planning goal is to again grow 500% between 4th quarters 2009 and 2010.
PURPOSE: Pure One™ marketing requires financing for re-launching its brand internationally. Funds raised and earned will help the company perform well during a period of rapid growth. The funds will help pay for business development, marketing and legal protections needed to support a fledgling brand. These are highly important for the development of the company. $200,000 is needed to Capitalize the company and ensure investor returns in 2 to 4 years.
THE SPECIFIC WORK AIMS:
Microalgae oil is a high-end clinical DHA product suitable for all ages and dietary choices with broad need and deficiency identified according to the omega-3 index.
BACKGROUND:
DR. SCOTT DOUGHMAN, PHD is Founder and President of Source-Omega, LLC. He is the recipient of several prestigious awards, including a Fellowship in Nutritional Biochemistry from the National Institutes of Health (NIH) for studying the Role of Omega-3s in Metabolic Diseases. Dr. Doughman has gone on to author several scientific research studies and two clinical review articles on source algae oil Omega-3s for Omega-3 DHA Therapy™ (Curr. Diabetes Rev, 2007; Submitted For Publication, 2010). Dr Doughman's Integrative Omega-3 Therapies have helped build Source-Omega, created Pure One™ and now his training based knowledge is driving essential writings, blogging, and articles on the topic, always searching for scientific, clinical, and context accuracy. Microalgae oil is THE SOURCE where fish Omega-3s come from. Scott went to the source. He came back with Pure One™. "The proof is in the results" says Scott. "We build clinical results our business is growing out of that essential service.”
SUMMARY DESCRIPTION OF THE BUSINESS:
Mission: to promote, deliver and measure Omega-3 DHA Therapy™ results.
Business Model: Manufacturer, Distributor, Branding, Marketing and R&D of OEM microalgae oil products that fill niches in omega-3 supplement marketplaces as lead offerings for omega-3s with DHA and EPA that are both vegan-friendly and diabetic-friendly.
Strategy: The objective is to build an international brand and product line distributed directly online and by wholesales around the world. Price controls, selecting partners, negotiating outlets in the USA and in other countries and quality of service are all strategies focused on for short- and long-term success.
SWOT ANALYSIS:
Strengths: Product Positioning, Niche, Clinical Authenticity, Product Quality, and Endorsements.
Weaknesses: Capitalization, Marketing Reach, Low Volume Outlets, Brand Awareness.
Opportunities: Entering sites in the USA & European Countries, New Liquid Product for Kids, Medicine and Nursing, Women’s Health, Pregnancy and Prenatal DHA. All New.
Threats: Increasing outside competition on price and increasing numbers of DHA competitors.
